EDIT: Nevermind. I didn't read thoroughly enough. All endpoints met!
Looks like the secondary endpoint on sleeping (I believe that is the other one) wasn't met. Not a surprise, given the failures of other inverse agonists in this regard, and shouldn't be a big deal. The p-value on the two most important endpoints was incredible!
Market Data 
Markets 
AI
